Cargando…

Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens

The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi, Seyed Ebrahim, Raza, Aun, Gholami, Max, Giles, Michael, Al-Sammak, Rayan, Ibrahim, Ali, Ebrahimi Shahmabadi, Hasan, Sharma, Lavanya A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692332/
https://www.ncbi.nlm.nih.gov/pubmed/36365112
http://dx.doi.org/10.3390/pharmaceutics14112293
_version_ 1784837238444523520
author Alavi, Seyed Ebrahim
Raza, Aun
Gholami, Max
Giles, Michael
Al-Sammak, Rayan
Ibrahim, Ali
Ebrahimi Shahmabadi, Hasan
Sharma, Lavanya A.
author_facet Alavi, Seyed Ebrahim
Raza, Aun
Gholami, Max
Giles, Michael
Al-Sammak, Rayan
Ibrahim, Ali
Ebrahimi Shahmabadi, Hasan
Sharma, Lavanya A.
author_sort Alavi, Seyed Ebrahim
collection PubMed
description The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic microorganisms, and consequently, oral infectious diseases. Systemic administration is frequently used for drug delivery in the treatment of diseases and is associated with the problems, such as drug resistance and dysbiosis. To overcome these challenges, oral drug delivery systems (DDS) have received considerable attention. In this literature review, the related articles are identified, and their findings, in terms of current therapeutic challenges and the applications of DDSs, especially nanoscopic DDSs, for the treatment of oral infectious diseases are highlighted. DDSs are also discussed in terms of structures and therapeutic agents (e.g., antibiotics, antifungals, antiviral, and ions) that they deliver. In addition, strategies (e.g., theranostics, hydrogel, microparticle, strips/fibers, and pH-sensitive nanoparticles), which can improve the treatment outcome of these diseases, are highlighted.
format Online
Article
Text
id pubmed-9692332
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96923322022-11-26 Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens Alavi, Seyed Ebrahim Raza, Aun Gholami, Max Giles, Michael Al-Sammak, Rayan Ibrahim, Ali Ebrahimi Shahmabadi, Hasan Sharma, Lavanya A. Pharmaceutics Review The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic microorganisms, and consequently, oral infectious diseases. Systemic administration is frequently used for drug delivery in the treatment of diseases and is associated with the problems, such as drug resistance and dysbiosis. To overcome these challenges, oral drug delivery systems (DDS) have received considerable attention. In this literature review, the related articles are identified, and their findings, in terms of current therapeutic challenges and the applications of DDSs, especially nanoscopic DDSs, for the treatment of oral infectious diseases are highlighted. DDSs are also discussed in terms of structures and therapeutic agents (e.g., antibiotics, antifungals, antiviral, and ions) that they deliver. In addition, strategies (e.g., theranostics, hydrogel, microparticle, strips/fibers, and pH-sensitive nanoparticles), which can improve the treatment outcome of these diseases, are highlighted. MDPI 2022-10-26 /pmc/articles/PMC9692332/ /pubmed/36365112 http://dx.doi.org/10.3390/pharmaceutics14112293 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Alavi, Seyed Ebrahim
Raza, Aun
Gholami, Max
Giles, Michael
Al-Sammak, Rayan
Ibrahim, Ali
Ebrahimi Shahmabadi, Hasan
Sharma, Lavanya A.
Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens
title Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens
title_full Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens
title_fullStr Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens
title_full_unstemmed Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens
title_short Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens
title_sort advanced drug delivery platforms for the treatment of oral pathogens
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692332/
https://www.ncbi.nlm.nih.gov/pubmed/36365112
http://dx.doi.org/10.3390/pharmaceutics14112293
work_keys_str_mv AT alaviseyedebrahim advanceddrugdeliveryplatformsforthetreatmentoforalpathogens
AT razaaun advanceddrugdeliveryplatformsforthetreatmentoforalpathogens
AT gholamimax advanceddrugdeliveryplatformsforthetreatmentoforalpathogens
AT gilesmichael advanceddrugdeliveryplatformsforthetreatmentoforalpathogens
AT alsammakrayan advanceddrugdeliveryplatformsforthetreatmentoforalpathogens
AT ibrahimali advanceddrugdeliveryplatformsforthetreatmentoforalpathogens
AT ebrahimishahmabadihasan advanceddrugdeliveryplatformsforthetreatmentoforalpathogens
AT sharmalavanyaa advanceddrugdeliveryplatformsforthetreatmentoforalpathogens